112 related articles for article (PubMed ID: 32491855)
1. Hexokinase II-Derived Cell-Penetrating Peptide Mediates Delivery of MicroRNA Mimic for Cancer-Selective Cytotoxicity.
Palanikumar L; Al-Hosani S; Kalmouni M; Saleh HO; Magzoub M
Biochemistry; 2020 Jun; 59(24):2259-2273. PubMed ID: 32491855
[TBL] [Abstract][Full Text] [Related]
2. Hexokinase II-derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells.
Woldetsadik AD; Vogel MC; Rabeh WM; Magzoub M
FASEB J; 2017 May; 31(5):2168-2184. PubMed ID: 28183803
[TBL] [Abstract][Full Text] [Related]
3. Self-assembly of mitochondria-specific peptide amphiphiles amplifying lung cancer cell death through targeting the VDAC1-hexokinase-II complex.
Liu D; Angelova A; Liu J; Garamus VM; Angelov B; Zhang X; Li Y; Feger G; Li N; Zou A
J Mater Chem B; 2019 Jul; 7(30):4706-4716. PubMed ID: 31364685
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-acting hexokinase II peptides carried by short-length carbon nanotubes with increased cellular uptake, endosomal evasion, and enhanced bioactivity against cancer cells.
Yoong SL; Lau WL; Liu AY; Prendergast D; Ho HK; Yu VC; Lee C; Ang WH; Pastorin G
Nanoscale; 2015 Sep; 7(33):13907-17. PubMed ID: 26219542
[TBL] [Abstract][Full Text] [Related]
5. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
6. A Lipidated Peptide with Mitochondrial Membrane Localization in Human A549 Lung Cells: From Enhanced Cell-Penetrating Properties to Biological Activity Mechanism.
Zhang X; Angelova A; Sun W; Zhang F; Li N; Zou A
ACS Appl Bio Mater; 2021 Dec; 4(12):8277-8290. PubMed ID: 35005910
[TBL] [Abstract][Full Text] [Related]
7. Intracellular Delivery of DNA and Protein by a Novel Cell-Permeable Peptide Derived from DOT1L.
Geng J; Guo X; Wang L; Nguyen RQ; Wang F; Liu C; Wang H
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32024261
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of cell-penetrating peptides and penetration accelerating sequence for nose-to-brain delivery of glucagon-like peptide-2.
Akita T; Kimura R; Akaguma S; Nagai M; Nakao Y; Tsugane M; Suzuki H; Oka JI; Yamashita C
J Control Release; 2021 Jul; 335():575-583. PubMed ID: 34116136
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-specific peptide amphiphiles induce mitochondrial dysfunction and peripheral T-cell lymphomas (PTCL) damage.
Sun Q; Gui A; Zou A; Yan Y; Qiu S; Zhu S; Liu W; Zuo J; Zhang Q; Yang L
Ann Transl Med; 2022 May; 10(10):570. PubMed ID: 35722364
[TBL] [Abstract][Full Text] [Related]
10. FV-429 induces apoptosis and inhibits glycolysis by inhibiting Akt-mediated phosphorylation of hexokinase II in MDA-MB-231 cells.
Zhou Y; Lu N; Qiao C; Ni T; Li Z; Yu B; Guo Q; Wei L
Mol Carcinog; 2016 Sep; 55(9):1317-28. PubMed ID: 26258875
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells.
Kaban K; Salva E; Akbuga J
Nucleic Acid Ther; 2017 Feb; 27(1):45-55. PubMed ID: 27763825
[TBL] [Abstract][Full Text] [Related]
12. Cell-Selective Delivery of MicroRNA with a MicroRNA-Peptide Conjugate Nanocomplex.
Xiao X; Wang X; Gao H; Chen X; Li J; Zhang Y
Chem Asian J; 2018 Dec; 13(24):3845-3849. PubMed ID: 30354014
[TBL] [Abstract][Full Text] [Related]
13. Gen-27, a newly synthesized flavonoid, inhibits glycolysis and induces cell apoptosis via suppression of hexokinase II in human breast cancer cells.
Tao L; Wei L; Liu Y; Ding Y; Liu X; Zhang X; Wang X; Yao Y; Lu J; Wang Q; Hu R
Biochem Pharmacol; 2017 Feb; 125():12-25. PubMed ID: 27818240
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
15. Targeted Delivery of Cabazitaxel Using Cyclic Cell-Penetrating Peptide and Biomarkers of Extracellular Matrix for Prostate and Breast Cancer Therapy.
Park SE; El-Sayed NS; Shamloo K; Lohan S; Kumar S; Sajid MI; Tiwari RK
Bioconjug Chem; 2021 Aug; 32(8):1898-1914. PubMed ID: 34309357
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-223 Targeting STIM1 Inhibits the Biological Behavior of Breast Cancer.
Yang Y; Jiang Z; Ma N; Wang B; Liu J; Zhang L; Gu L
Cell Physiol Biochem; 2018; 45(2):856-866. PubMed ID: 29414804
[TBL] [Abstract][Full Text] [Related]
17. Non-Peptidic Cell-Penetrating Motifs for Mitochondrion-Specific Cargo Delivery.
Appiah Kubi G; Qian Z; Amiar S; Sahni A; Stahelin RV; Pei D
Angew Chem Int Ed Engl; 2018 Dec; 57(52):17183-17188. PubMed ID: 30376611
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Targeting Peptide Binds Keratin 1: A New Molecular Marker for Targeted Drug Delivery to Breast Cancer.
Soudy R; Etayash H; Bahadorani K; Lavasanifar A; Kaur K
Mol Pharm; 2017 Mar; 14(3):593-604. PubMed ID: 28157321
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells.
Mobarra N; Shafiee A; Rad SM; Tasharrofi N; Soufi-Zomorod M; Hafizi M; Movahed M; Kouhkan F; Soleimani M
In Vitro Cell Dev Biol Anim; 2015 Jun; 51(6):604-11. PubMed ID: 25672252
[TBL] [Abstract][Full Text] [Related]
20. EJP18 peptide derived from the juxtamembrane domain of epidermal growth factor receptor represents a novel membrane-active cell-penetrating peptide.
Eissa NG; Sayers EJ; Birch D; Patel SG; Tsai YH; Nielsen HM; Jones AT
Biochem J; 2020 Jan; 477(1):45-60. PubMed ID: 31820794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
